
![]() |
![]() |
|||||||||
| Mickael A. Flaa | ||||||||||
Vice President, Chief Financial Officer Mr. Flaa is VP & CFO of Phage Biotechnology Corporation, a related party. He also remains involved in the management and/or board of directors of several additional ventures: Onnam Gaming, and Gestalt, LLC. Flaa spent 22 years in various management positions with KPMG Peat Marwick LLP, where he was elected to partnership in 1990. He worked with clients in fields including health care, technology, utilities, transportation and energy. Flaa received his undergraduate degree from Central Washington University.
< Back to Officers & Key Personnel
Use of
this site constitutes agreement to our Terms and Conditions | ||||||||||
12/11/2008
CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial